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Abstract
Next-generation sequencing technology allows investigation of both common and rare variants
in humans. Exomes are sequenced on the population level or in families to further study the
genetics of human diseases. Genetic Analysis Workshop 17 (GAW17) provided exomic data
from the 1000 Genomes Project and simulated phenotypes. These data enabled evaluations of
existing and newly developed statistical methods for rare variant sequence analysis for which
standard statistical methods fail because of the rareness of the alleles. Various alternative
approaches have been proposed that overcome the rareness problem by combining multiple rare
variants within a gene. These approaches are termed collapsing methods, and our GAW17 group
focused on studying the performance of existing and novel collapsing methods using rare
variants. All tested methods performed similarly, as measured by type I error and power. Inflated
type I error fractions were consistently observed and might be caused by gametic phase
disequilibrium between causal and noncausal rare variants in this relatively small sample as well
as by population stratification. Incorporating prior knowledge, such as appropriate covariates and
information on functionality of SNPs, increased the power of detecting associated genes.
Overall, collapsing rare variants can increase the power of identifying disease-associated genes.
However, studying genetic associations of rare variants remains a challenging task that requires
further development and improvement in data collection, management, analysis, and
computation.
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Introduction
Genome-wide association studies have successfully identified hundreds of novel genetic
loci associated with complex disease traits. In most cases, only a small portion of the heritability
is explained by these associated common variants [Manolio et al., 2009; Eichler et al., 2010].
Although the summation of these associated loci may underestimate the total amount of
heritability that common variants can explain [Yang et al., 2010], rare genetic variants might also
contribute a sizable proportion of the genetic susceptibility to common diseases. In contrast to
common variants associated with small effects, rare variants with putative functional change,
such as nonsynonymous single-nucleotide polymorphisms (SNPs), are more likely to have a
larger effect [Kryukov et al., 2007; Gorlov et al., 2008].
Current technology allows an exhaustive search for rare variants by sequencing the whole
genome of a human being [Lee et al., 2010; Lupski et al., 2010; Sobreira et al., 2010]. Although
the cost has drastically decreased in recent years, conducting a whole-genome sequencing project
may not be cost-efficient for identifying functional rare variants associated with common
diseases. The 30 million base pairs of the human exome account for about 1% of the whole
human genome. With a fixed budget, an exome sequencing project can survey a much larger
sample (required for detecting rare variants) with better coverage of the sequence reads (higher
quality of the calls of rare variants). Several studies have demonstrated the utility of exome
sequencing in identifying functional variants related to human diseases [Bilguvar et al., 2010;
Gilissen et al., 2010; Ng et al., 2010a, 2010b; Walsh et al., 2010].
Because of the low allele frequencies, traditional regression-based methods do not work
well with rare variants derived from sequencing data. To address the analytical challenge of
identifying rare genetic variants associated with diseases, investigators have developed a number
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of collapsing methods to summarize the individual rare variants in association analyses. These
methods have been described in detail by Dering et al. [2011a]. Genetic Analysis Workshop 17
(GAW17) provided exome sequencing data from the 1000 Genomes Project and simulated
phenotypic traits, both binary and quantitative [Almasy et al., 2011]. These simulated data sets
with a large number of rare variants can be used to evaluate the existing and newly proposed
methods to identify the associations of rare variants. For exome sequencing data, a natural unit
for collapsing genetic variants is the gene. Although many of these collapsing methods can be
used for common variants, GAW17 Group 15 focused on the methods’ performance in
identifying associations of rare variants, sometimes jointly with common variants.
All 12 contributions to GAW17 Group 15 used the simulated data of 697 unrelated
individuals. Taking advantage of 200 simulated data sets (simulated phenotypes with measured
genotypes from the 1000 Genomes Project) of one binary trait and three quantitative traits and
the available underlying genetic models, many contributors assessed type I error and power of
existing and novel collapsing methods. These evaluations and comparisons help us to understand
the performance of these methods in terms of both type I error and power.
Several existing collapsing methods for rare variant analysis—collapsing and summation
test (CAST), indicator coding test RVT2 (rare variant test 2), combined multivariate and
collapsing (CMC) method, weighted-sum (WS) collapsing method, data-adaptive summation
(aSUM), and variable threshold (VT) collapsing method—have been assessed by Group 15
contributors. The CMC, WS, aSUM, and VT methods also provide flexible frameworks with
which to analyze collapsed rare variants and common variants jointly. These methods have been
summarized by Dering et al. [2011a]. Here, we describe novel approaches suggested and
explored by Group 15 contributors.
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Collapsing Methods for Rare Variant Analysis: Cumulative Minor Allele Test {AU:
Because there is only one subhead, we can combine the main head and the subhead. This is
standard practice for journals and books.}
The cumulative minor allele test (CMAT) for rare variant analysis is derived from the
chi-square statistic and compares the total number of rare variants present in the gene for case
subjects and control subjects [Zawistowski et al., 2010]. For a sample with NA case subjects and
NU control subjects, assume F > 1 variants in the region of interest (ROI), each with a weighting
factor wj ≥ 0 (j = 1, …, F). The CMAT statistic compares the proportion of rare alleles in the
case subjects to the proportions in the control subjects as follows:

 mA M U  mU M A  ,
N A  NU

2 N A NU  j w j  m A  mU  M A  M U 
2

CMAT

(1)
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F
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mU   w jYij

(3)

i 1 j 1
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are the weighted minor allele counts across all sites in the ROI for case and control subjects,
respectively.
Because the genetic variants may be in linkage disequilibrium and have small counts, a
permutation strategy that shuffles the case-control labels and maintains the correlation structure
of the genetic data is used to determine the statistical significance of the CMAT statistic. Luedtke
et al. [2011] evaluated CMAT along with the CMC, WS, and RVT2 methods for their
performance in analyzing the dichotomized trait. One thousand permutations were performed to
determine the empirical p-value of each gene, that is, the ROI [Luedtke et al., 2011].

Genetic Similarity and Distance
An alternative approach to studying genetic associations is to investigate the relationship
between pairs of individuals. This approach can be particularly useful for identifying clusters of
individuals in the phenotype-genotype space. Methods based on correlating genotypic similarity
and phenotypic similarity have been developed for genetic epidemiological research [Shannon et
al., 2002; Beckmann et al., 2005]. In GAW17 Group 15, two pairwise approaches, one based on
the kernel function and the other based on the Mantel test, were implemented and assessed using
the GAW17 data.

Kernel-Based Association Test
The kernel-based association test (KBAT) combines multiple genetic variants and
reduces the degrees of freedom and was initially proposed to study the genetic association of
common variants [Kwee et al., 2008]. KBAT extends the least-squares kernel machines for
quantitative traits and the logistic kernel machine for dichotomized traits to study multivariable
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associations [Kwee et al., 2008; Wu et al., 2010]. Li et al. [2011] implemented and investigated
the KBAT because it is suitable for combining multiple rare variants within a ROI. For
quantitative traits, β and h are estimated by maximizing the penalized likelihood function

J ( h,  )  

2
1 n
1
2
 yi  X iT   h(Gik )    h ,

2 i 1
2

(4)

where λ is a tuning parameter. The solution to the nonparametric function h(·) can be expressed
as

n

h(G )   i K (G, Gik )

(5)

i 1

for a given kernel function k(·, ·). {AU: In the preceding sentence, should the k in k(·, ·) be
capitalized, i.e., K(·, ·), to match Eq. 5 and the subsequent text?} The kernel function K(Gik, Gjk)
measures the genetic similarity between two individuals i and j at the SNPs in gene k. The
estimates of β and α (equivalently, h) can be obtained by plugging h(G) into the penalized
likelihood function.
Li et al. [2011] implemented the kernel function based on genetic similarity measured by
identity-by-state (IBS) sharing between two individuals i and j at the SNPs within gene k. To
consider the potentially larger effect of the genetic variants with lower frequency, this flexible
kernel function can be weighted by minor allele frequency (MAF) q, as follows:
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where Mrik denotes the genotype of individual i at SNP r in gene k and wlk is a weight based on
qlk (the MAF of SNP l within gene k) and equals 1/( qlk)1/2.

Mantel Test
Instead of directly testing the associations between rare variants or their collapsed
summary statistics, Sun et al. [2011] implemented a collapsing method to examine the
correlation between the genetic dissimilarity (i.e., the genetic distance) and phenotypic
dissimilarity. This method is a Mantel-type statistic that tests the dependence between the
elements of two matrices [Mantel, 1967]. The two matrices contain data from multiple variables
obtained on a common sample of subjects, where the rows correspond to the subjects and the
columns contain data on the two sets of variables X and Y. For n subjects with two variables X
and Y, two distance matrices, each with n(n − 1)/2 pairwise distances, are first calculated. The
Mantel statistic is based on the cross-product term

n

n

Z   X ijYij ,

(7)

i 1 j 1

where n denotes the number of subjects in the distance matrices and Xij and Yij are the pairwise
distances between subjects i and j. The elements of a distance matrix are not independent, and
determination of the type I error level for the correlation (i.e., Mantel’s statistic Z) between two
distance matrices is not straightforward. Therefore the significance level is usually evaluated
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using a permutation procedure [Beckmann et al., 2005]. For a given gene, the genetic distance Xij
between each pair of subjects is calculated as the sum of difference of the additive effect on each
rare SNP. For a SNP, the distance between two homozygotes is 2, but the distance is 1 between
homozygote and heterozygote genotypes. The genetic distance between a pair of subjects on the
gene level is the sum of the genetic distance of individual SNPs. For a gene involving two SNPs
with alleles A/a and B/b, the genetic distance between a pair of individuals ranges from 0 (same
genotype) to 4 (AABB vs. aabb). The phenotypic distance is the absolute difference of the
phenotypic value between a pair of individuals (|Yi − Yj|).

Integrated Analysis of Both Rare and Common Variants

As shown in several previous studies [Li and Leal, 2008; Madsen and Browning, 2009],
combining rare and common variants within a ROI can improve the power of identifying a
disease-associated region when both types of genetic variants contribute to the disease. Two
Group 15 studies proposed alternative approaches to jointly analyzing rare and common variants
by applying variable selection and the least absolute shrinkage and selection operator (LASSO)
[Dasgupta et al., 2011].

Data-Adaptive Forward Selection
Dai et al. [2011] proposed a three-step procedure that uses the associated common SNP
as an anchor to select the rare variants. The variable selection procedure starts with selecting the
most significant common SNP in the ROI. Then the rare SNPs that improve the goodness-of-fit
are added to the model one at a time. The selection of rare SNPs repeats until no such rare SNP
exists in the ROI. The goodness-of-fit is measured by the F statistic of a linear regression model
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that combines the selected variants into a collapsing score. The final test statistic is the absolute
value of the t statistics for the final linear regression model E(y) = α + βSfinal, where Sfinal is the
final collapsed score including all selected common and rare variants. Without knowledge of the
distribution of the final t statistic, a genome-wide permutation needs to be performed to evaluate
the global empirical p-value. This data-adaptive forward selection procedure selectively chooses
only variants that improve the joint association between the ROI and the disease trait.

LASSO
The LASSO is an efficient variable selection method for high-dimensional data analysis
[Tibshirani, 1996]. Recently, the LASSO and its variants have been adapted to the analysis of
high-dimensional genetic variants [Szymczak et al., 2009; Dasgupta et al., 2011]. Chen et al.
[2011] applied LASSO regression to select common variants that should remain in the model.
They performed a 10-fold cross-validation for estimating the shrinkage parameter (λ) for the
LASSO. The common variants remaining in the model after LASSO selection and the covariates
and rare variant score were then fitted in a multiple regression model. The joint genetic
association of common and rare variants was tested using the partial F test.
Table I summarizes the analyses of rare variants performed by GAW17 Group 15
contributors. Both the quantitative traits and the dichotomized trait were analyzed. Because the
contributors decided to be either blinded or unblinded to the simulation answers, the analytical
strategies discussed during the GAW17 meetings were heterogeneous. However, all contributors
chose to use similar analytical approaches in their final contributions. Given the causal genetic
associations simulated in 200 replicates, all work groups evaluated the performance of existing
or novel approaches by testing type I error fraction and power [Chen et al., 2011; Dai et al.,
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2011; Dering et al., 2011b; Luedtke et al., 2011; Sun et al., 2011] or receiver operating
characteristic (ROC) curves with similar measurements [Li et al., 2011; Lin et al., 2011; Sung et
al., 2011]. Because all causal SNPs were nonsynonymous in the simulation model, six out of
nine work groups examined the performance of collapsing methods by including
nonsynonymous SNPs only. Almost all contributors implemented permutation tests to determine
the statistical significance resulting from the nonstandard distribution of the test statistics derived
from the collapsing methods. The inclusion of covariates was also considered to assess its impact
on the performance of these methods.

Results

After extensive investigations of the collapsing methods for rare variant analysis, we
observed several common themes in our group. Although the power can be improved under
specific scenarios, such as filtering nonsynonymous SNPs and inclusion of appropriate
covariates, the overall performance of all tested methods was similarly poor. By adjusting for
multiple testing of thousands of genes, all collapsing methods were underpowered to detect
genes with causal rare variants in 697 unrelated samples except for a few top genes, such as
FLT1 and KDR for the simulated quantitative trait Q1.
We also observed surprisingly high type I error fractions for Q1 and Q2 across all tested
methods. For Q4, which did not have any causal genetic variants simulated, the type I error
fraction of the tested methods was not inflated. Two work groups in Group 15 further
investigated the potential causes of the inflated type I error [Luedtke et al., 2011; Sung et al.,
2011] and identified hundreds of SNPs in gametic phase disequilibrium with the causal rare
variants. Gametic phase disequilibrium, also called gametic disequilibrium, is the nonrandom

11

correlation between genetic loci. Here, we use the term to define such nonrandom correlation
between loci that are located beyond a local haplotype block, sometimes on different
chromosomes. In extreme cases, a noncausal SNP had identical genotypes as the causal SNP for
all 697 individuals.
Another potential cause of inflated type I error is population structure. Principal
components analysis (PCA), which is used to adjust for population structure, reduces type I error
[He et al., 2011; Luedtke et al., 2011], but the effectiveness of controlling the false positives is
influenced by the MAF [He et al., 2011]. Specifically, PCA reduced false-positive fractions more
effectively in common SNPs (MAF > 0.05) than in rare SNPs (MAF < 0.01). Unfortunately,
although false-positive fractions were reduced, the power to detect true associations was also
reduced by using PCA.
Not surprisingly, we confirmed that the power for identifying associations of rare variants
can be improved by including the appropriate prior knowledge. For instance, incorporating the
correct covariates in the model increased both sensitivity and specificity [Lin et al., 2011]. In
addition, the power to identify associated genes increased by selecting only the nonsynonymous
SNPs for all collapsing methods, because all causal rare variants were nonsynonymous SNPs in
the simulation model. Meanwhile, the synonymous-SNPs-only test served as a negative control
for assessing the false-positive fraction. Given that all simulated effects of rare variants were
deteriorating, the data-adaptive methods, such as the aSUM method, did not perform better than
the non-data-adaptive methods.
We also observed interesting features of some novel approaches. The forward selection
method combining both common and rare variants achieved substantially higher power than
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other methods, which considered either rare or common variants regardless of their associations
with the outcome [Dai et al., 2011].

Discussion

Inflation of Type I Error
Overall we found that collapsing methods had limited capability to identify most causal
genes because of low power and high type I error fraction. Inflated type I error fractions were
consistently observed for simulated traits using all collapsing methods. The expected type I error
for Q4, which has no causal variants, suggested that the inflation was not due to the statistical
methods. A large number of SNPs in noncausal genes were in gametic phase disequilibrium with
causal SNPs simulated for Q1 and Q2 [Li et al., 2011; Luedtke et al., 2011; Sung et al., 2011];
that is, they were highly correlated with causal SNPs. These highly correlated or even identical
genotypes may account for the large number of false-positive genes for Q1, Q2, and the affection
status. Because the number of rare variants (especially the private mutations observed only once
in the sample) was much larger than the sample size, it was more likely that causal and noncausal
variants shared the same or similar genotype distributions. For the sample size of 697, at least
two private mutations were on the same individual’s genome among every 698 rare variants with
private mutations. These pairs of rare variants, which may include simulated causal variants, had
perfect correlation. The spurious correlations among causal and noncausal rare variants could
have been caused by gametic phase disequilibrium and population stratification [Luedtke et al.,
2011]. A further analysis showed a higher amount of gametic phase disequilibrium than random
chance, which suggests potential genotyping errors from the exomic sequencing; however, no
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information about genotype calling, cleaning, or other preprocessing steps were available for
these data to allow us to further pinpoint the cause.

Permutation and Computation
Because of the unknown distribution of the test statistics and because of potential
correlation among genetic variants, the Group 15 contributors needed to use permutation to
accurately determine the statistical significance for most collapsing methods of rare variant
analysis. Permutation is a computationally expensive procedure that generates the null
distribution of the test statistic by deconstructing the relationship between predictors and
outcome repeatedly. Permutation of high-dimensional data requires a large amount of
computational resources. To achieve a significant empirical p-value adjusted for multiple testing,
investigators need hundreds of thousands of permutations to scan the human exome. In a
simplified example, a Bonferroni-corrected p-value of 0.05 for 20,000 human genes requires at
least 400,000 permutations (1/(0.05/20,000)). Although the total number of human genes is
approximately fixed in the equation, other factors (e.g., a non-gene-based ROI) might increase
the total number of permutations needed.
Improvements in both software and hardware can address this computational challenge.
Well-implemented algorithms can greatly speed up the computation of high-throughput data for
genetic epidemiological studies [Schwarz et al., 2010]. A large number of permutations can also
be easily parsed into smaller jobs to take advantage of parallel computing available in all highperformance computing facilities and smaller scale computer clusters. The multicore design of
the latest CPUs and graphic processing units (GPUs) combined with parallel programming
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techniques will help genetic epidemiologists to address computational challenges in analyzing
rare variants and sequencing data.
On the other hand, genetic epidemiologists start to face another issue of data
management: how to securely transfer, store, and back up the large amount of sequencing data
(terabytes rather than gigabytes). A well-designed computation environment will be critical to
conquer these technical bottlenecks for analyzing next-generation sequencing data. More
important, like all new forms of data for genetic epidemiological studies, the next-generation
sequencing data need to be carefully examined and cleaned. The issue of data quality cannot be
overemphasized at the early stage of the analysis of next-generation sequencing data. The valid
scientific findings have to rely on high-quality sequencing data that are likely to be more critical
for studying rare variants.

Real Data Analysis: The More We Know, the More We Know What We Don’t Know
One of the biggest questions still unanswered after extensive studies of simulated data is
how to best analyze the real data with many rare variants from sequencing projects. With limited
simulation models, we are not able to evaluate all scenarios where these assumptions are
violated. In practice, we do not know the location and effect of noncoding causal variants (e.g.,
cis-regulatory elements), the proportion of causal variants that change protein coding
(nonsynonymous vs. synonymous SNPs), the weight of a genetic variant relative to the allele
frequency, the direction of the genetic effects (deteriorating vs. protective), or the boundary of an
ROI. In that regard, the data-adaptive approaches and methods that require minimal assumptions
are more favorable. Several interesting directions should be considered or combined in the future
analysis of rare variants. The aSUM statistic addresses the issue that causal variants may not
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have effects all in one direction. Unfortunately, the GAW17 data simulated only deteriorating
effects that do not allow a formal test to examine the benefit of this flexible approach. The
weighted KBAT seems to be less sensitive to the assumption of lower MAF and larger effect
size. It suffers less power loss than the WS method when this assumption is violated [Li et al.,
2011].
All Group 15 contributors chose the gene, a natural unit of the human genome, as the
ROI for collapsing genetic variants. However, the ROI can also be based on nongenic regions,
such as transcriptional regulatory regions, functional domains within a gene, or a set of related
genes (e.g., a protein complex or a pathway) [Dering et al., 2011a; Tintle and Pugh, 2011]. The
benefits of choosing alternative ROIs cannot be assessed using the GAW17 data because of the
limitation of the simulation. In real data analysis, using an alternative collapsing unit may help to
identify disease-related molecular mechanisms by enriching the genetic signal.
Sequencing data provide the ultimate resolution of the genetic variants in human DNA.
With large populations sequenced, eventually we will be able to identify the causal genetic
associations on the human genome. With the improvements in measurement, data processing,
management, and methods of analysis, we will be able to further understand the genetic causes
of complex diseases and develop strategies to deliver better prevention, diagnosis, and treatment
to the public.
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Table I. Overview of Group 15 contributions
Contribution

Phenotype

Collapsing method

Rare SNP MAF (%)

SNP filter

Type I error

Power

Permutation

Chen et al. [2011]

Q1, Q4

RVT, aSUM, CMC, LASSO

0.5, 1, 5

All

Y

Y

Y

Dai et al. [2011]

Q1, Q2

Forward selection, CAST, WS,

1

All

Y

Y

Y

RVT
Dering et al. [2011b]

Affected

CAST, CMC, WS, RVT

1, 2, 3, 5, 7, 10

All, nsyn, syn

Y

Y

Y

He et al. [2011]

Q1

RVT, aSUM

1

nsyn

Y

Y

Y

Li et al. [2011]

Q1, Q2, Q4, Affected CMC, WS, KBAT, Bayesian

5

nsyn, syn

Y

Y

Y

mixed-effects model
Lin et al. [2011]

Q1, Q2, Q4, Affected VT, WS, RVT

1, 5

All

Y

Y

Y

Luedtke et al. [2011]

Affected

CMC, WS, RVT, CMAT

5

All, nsyn

Y

Y

Y

Sun et al. [2011]

Q1, Q4, Affected

Mantel test

5

All, nsyn

Y

Y

Y

Sung et al. [2011]

Q1, Q2

RVT

5

All, nsyn

Y

Y

N

CAST, collapsing and summation test; CMC, combined multivariate and collapsing method; WS, weighted-sum method; aSUM,
adaptive summation method; RVT, rare variant test; VT, variable threshold method; CMAT, cumulative minor allele test; KBAT,
kernel-based association test; nsyn, nonsynonymous; syn, synonymous.
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